Treatment of neuropathic pain

A neuropathy, benzoic acid technology, applied in nervous system diseases, metabolic diseases, organic active ingredients, etc., can solve problems such as non-recovery, poor response to neuropathic pain, etc.

Inactive Publication Date: 2010-06-09
NUON THERAPEUTICS PTY LTD
View PDF17 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Unfortunately, neuropathic pain often responds poorly to standard pain treatments and sometimes gets worse rather than better over time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment of neuropathic pain
  • Treatment of neuropathic pain
  • Treatment of neuropathic pain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0179] To study the efficacy and efficacy of tranilast's oral feeding tube bolus administration regimen against allodynia in a rat model of painful diabetic neuropathy (PDN): dose-response curve

[0180] Preliminary dose identification in STZ-diabetic rats. Once tactile allodynia is completely produced (PWT6g; 8-11 weeks after STZ administration), the STZ-diabetic rat group was given an oral feeding tube bolus dose of carrier or trani Sate (30, 100, 200, 300 mg / kg) or subcutaneous bolus dose of gabapentin (100 mg / kg). Each rat first received 7 continuous bolus doses, with the same dose range, given twice a day with 10-14 hour intervals. The baseline PWT was assessed before the first, third, fifth, and seventh doses of Tranilast or gabapentin were administered. After the seventh oral feeding tube bolus dose of Tranilast was given, the PWT of the hind paw was quantitatively determined at the following times: before administration, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2 and 3 hours after...

Embodiment 2

[0183] To study the anti-allodynia efficiency and efficacy of tranilast's oral feeding tube bolus dosing regimen in the original STZ-diabetic rats

[0184] Dose-response curve of Tranilast in STZ-diabetic rats. Once tactile allodynia is completely generated (PWT 6g; 8-11 weeks after STZ administration), 100 (n=4), 200 (n=4), 300 (n=5) or 400 (n=4) mg / Tranilast was administered to the original STZ-diabetic rats with a bolus dose of 1 kg of oral feeding tube for 7 consecutive doses. Using the same dosing schedule described above, the control animals received a subcutaneous bolus dose of gabapentin (100 mg / kg; n=4) or an oral feeding tube bolus dose of the vehicle (n=4). PWT was determined using the above method. The baseline PWT was detected before the first, third, fifth, and seventh doses of Tranilast, gabapentin, or vehicle were administered. After giving the seventh continuous bolus dose twice a day at 10-14 hour intervals, the animals were also subjected to an enhanced Van...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A method of decreasing neuropathic pain in a mammal, comprising administering to said mammal an effective amount of tranilast for a period of time sufficient to decrease pain.

Description

Invention field [0001] The present invention relates generally to neuropathic pain, including the treatment of pain associated with diabetic retinopathy. Background of the invention [0002] The physical causes of pain can be divided into two categories: nociceptive pain and neuropathic pain. These differences are essential for understanding the nature of pain problems, especially for determining how to treat pain. [0003] Nociceptors are nerves that sense and react to injured parts of the body. They signal tissue irritation, impending injury or actual damage. When activated, they deliver pain signals. Pain is usually well-located and constant, often accompanied by pain or pulsation. Visceral pain is a subclass of nociceptive pain involving internal organs. It is often paroxysmal and poorly located. Examples include sprains, fractures, burns, bruises, contusions, inflammation (caused by infection or arthritic disease), obstruction, and myofascial pain (which can indicate abn...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01N37/44A61K31/195
CPCA61K31/196A61P25/02A61P3/00A61P3/10
Inventor M·L·塞利
Owner NUON THERAPEUTICS PTY LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap